PMID: 15346718Sep 7, 2004Paper

Copper treatment alters the barrier functions of human intestinal Caco-2 cells: involving tight junctions and P-glycoprotein

Human & Experimental Toxicology
Zhiwei Liu, Bingheng Chen

Abstract

This study investigated the effects of copper on paracellular permeability and P-glycoprotein (P-gp) in Caco-2 cells. Apical treatment with 100-300 microM CuSO4 in Hanks' balanced salt solution (HBSS, up to 3 hours) induced a time- and concentration-dependent increase in permeability of Caco-2 cell monolayers monitored by transepithelial electrical resistance (TEER). Copper treatment also induced a concentration-dependent reduction of F-actin stain, but not of tight junctional protein ZO-1. In addition, without any adverse effects on TEER, apical treatment with 300 microM CuSO4 in complete medium (for 24 hours) could reduce basolateral-to-apical transport, and increase apical-to-basolateral transport of rhodamine-123 (Rho-123) and accumulation of Rho-123 in Caco-2 cells. Treatment with 10-100 microM CuSO4 in HBSS (up to 3 hours) also induced a time- and concentration-dependent increase in accumulation of Rho-123 in Caco-2 cells. The results indicated that copper treatment increased the paracellular permeability probably by perturbing F-actin skeleton, and inhibited P-gp, thus altering the barrier functions of Caco-2 cells.

References

Feb 21, 1998·The American Journal of Physiology·T A Appel
Mar 4, 1999·Toxicology and Applied Pharmacology·E DuizerJ P Groten
Dec 20, 1999·Pharmaceutical Research·J M Dintaman, J A Silverman
Dec 22, 1999·The American Journal of Physiology·S FerruzzaY Sambuy
May 12, 2000·Toxicology in Vitro : an International Journal Published in Association with BIBRA·T OkadaM Shimizu
Sep 21, 2000·Journal of the American Animal Hospital Association·R L Pyle
Mar 22, 2001·Advanced Drug Delivery Reviews·P ArturssonK Luthman
Apr 27, 2001·Toxicology Letters·O van Tellingen
Jun 16, 2001·Regulatory Toxicology and Pharmacology : RTP·M OlivaresR Uauy
Oct 18, 2001·Regulatory Toxicology and Pharmacology : RTP·M ArayaK A Poirier
Jul 12, 2002·Toxicology in Vitro : an International Journal Published in Association with BIBRA·S FerruzzaY Sambuy
Sep 5, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Bhagwant D RegeJames E Polli
Nov 26, 2002·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jason ZastreHelen Burt
May 15, 2003·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Aqel W Abu-QareMohamed B Abou-Donia
Sep 2, 2003·Pharmaceutical Research·Matthew D Troutman, Dhiren R Thakker
Feb 1, 1996·Toxicology in Vitro : an International Journal Published in Association with BIBRA·A RossiM L Scarino
Aug 1, 1999·Toxicology in Vitro : an International Journal Published in Association with BIBRA·G VelardeJ M Porcher

❮ Previous
Next ❯

Citations

May 26, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Brian A KoenemanDavid G Capco
Dec 17, 2019·Journal of Animal Physiology and Animal Nutrition·Yang GaoLianyu Yang
Jan 1, 2019·Molecular & Cellular Toxicology·Ki Hyung KimYuseok Moon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.